2023
DOI: 10.1097/cm9.0000000000002511
|View full text |Cite
|
Sign up to set email alerts
|

Eosinophilic gastroenteritis: Pathogenesis, diagnosis, and treatment

Abstract: Eosinophilic gastroenteritis (EGE) is a gastrointestinal disorder of unclear etiology that is characterized by eosinophilic infiltration of the stomach and small intestine, and consists of mucosal, muscular, and serosal subtypes. Eosinophilic infiltration of the gastrointestinal tract is a fundamental histopathological characteristic of EGE and is driven by several T-helper type 2 (Th2)-dependent cytokines and induced by food allergy. Due to the lack of a diagnostic gold standard, EGE has a high rate of delaye… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 79 publications
0
2
0
Order By: Relevance
“…A comprehensive differential diagnosis is crucial when managing patients with recurrent intestinal obstruction. Conditions such as Crohn's disease, gastrointestinal malignancies, and other gastrointestinal disorders may present with similar symptoms, necessitating careful evaluation and consideration of all relevant clinical information [ 8 ].…”
Section: Discussionmentioning
confidence: 99%
“…A comprehensive differential diagnosis is crucial when managing patients with recurrent intestinal obstruction. Conditions such as Crohn's disease, gastrointestinal malignancies, and other gastrointestinal disorders may present with similar symptoms, necessitating careful evaluation and consideration of all relevant clinical information [ 8 ].…”
Section: Discussionmentioning
confidence: 99%
“…For these reasons, our patient was treated with infliximab but did not show clinical remission. Abnormally increased eosinophil infiltration in the stomach and bowel is a key histopathological characteristic of non-EoE EGIDs [ 21 ]. Omalizumab, a humanized monoclonal antibody targeting the high-affinity IgE receptor, can reduce eosinophilia in the peripheral blood, bronchus, skin, and gut.…”
Section: Discussionmentioning
confidence: 99%